Enjoy complimentary customisation on priority with our Enterprise License!
According to the market research analysts at Technavio, the global animal antibacterial and antibiotics market is anticipated to witness steady growth and will post a moderate CAGR of more than 5% over the forecast period. A sharp rise in pet ownership has led to a significant rise in demand for animal health products such as antibacterial and antibiotics. Such animal health products are intended to enhance the quality of life of these animals. The increasing recognition of pets as family members has diverted the focus toward better health care services for them. Also, the participation of animals in sports also necessitates regular care for these animals to ensure optimal performance. Furthermore, with the advancements in veterinary therapeutics and preventive medicines, along with an increase in disposable income is expected to boost the demand for better care for pets and livestock.
One of the recent trends spurring this market’s growth is the increasing collaborations between academic institutions and leading companies in the market to develop novel products for animal healthcare. For example, in 2013, The Roslin Institute at the University of Edinburgh and Zoetis collaborated to jointly investigate the entry route, mechanism of persistence in cattle, and beef contamination by Salmonella. Such collaborations enable the incorporation of research expertise of academic institutions with the marketing intelligence of pharma companies, contributing to the market’s growth.
The global animal antibacterial and antibiotics market is highly fragmented owing to the presence of several well-established large and small vendors. The vendors collaborate or acquire other vendors to stay competitive in the market. The smaller vendors are increasingly adopting organic growth strategies to improve their presence in the market.
Key vendors in this market are -
Other prominent vendors in the market include Animal Medics, Biogénesis Bagó, Bio-Vet, Boehringer Ingelheim Vetmedica, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Mobedco-Vet (The Arab Pesticides & Veterinary Drugs), Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac, and Vitafor.
During 2015, the tetracyclines was the highest revenue contributing segment and is likely to continue to its dominance over the coming years. Tetracyclines are broad-spectrum antibiotics, which are derivatives of polycyclic naphthacene carboxamide. This is the largest class of drugs administered to animals as they act by inhibiting bacterial translation, thereby preventing protein synthesis. Also, these drugs are not only used for their antibacterial properties but also for promoting growth and enhancing performance, leading to their augmented adoption.
In terms of geography, the Americas accounted for the majority of market shares and will continue to lead the market during the forecast period. The US was the highest revenue contributor in the region, thereby holding a significant portion of the global market. Factors such as the high prevalence of zoonotic diseases and increase in awareness of animal healthcare will aid in this market’s growth in the Americas.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Veterinary drug approval process
PART 06: Antibacterial: Overview
PART 07: Market landscape
PART 08: Market segmentation by chemical class
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
PART 17: Appendix
PART 18: Explore Technavio
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.